- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03631212
Avatar-led Acceptance and Commitment Therapy Smoking Cessation (Flexiquit)
August 17, 2018 updated by: Maria Karekla, University of Cyprus
An Avatar-led Acceptance and Commitment Therapy Intervention Promotes Smoking Cessation in Young Adults
Smoking remains a global concern, especially for youth where developmentally-suited smoking cessation programs are lacking and especially among those not presenting for treatment on their own.
We aimed to assess the effectiveness of an avatar-led digitalized smoking cessation intervention (Flexiquit) based on Acceptance and Commitment Therapy (ACT) for young adult smokers at all levels of motivation to quit.
Study Overview
Detailed Description
Cigarette smoking is associated with various health problems, particularly certain forms of cancer and early death (Centers for Disease Control and Prevention, 1997).
More recently, smoking has become a global problem among youth and it is imperative that research puts an emphasis on prevention and intervention particularly in this age group (World Health Organization, 2009).
Over the past few years, research has shown that internet-based interventions are more cost effective, cater to individuals who are unable/unwilling to attend weekly treatment sessions with a therapist, and are promising in terms of improving attrition rates, a major problem with most treatment trials.
Moreover, internet-based interventions use technology often utilized to attract youth (interactive games, animation, video clips etc.) and thus may reach and engage a wider range of individuals than traditional face-to-face interventions.
ACT is an empirically-based intervention that uses acceptance and mindfulness strategies and has been shown to increase psychological flexibility.
The aim of the present study is to investigate the usefulness and effectiveness of an Acceptance and Commitment Therapy (ACT) internet-based smoking cessation intervention program for college, high school and vocational school student smokers.
Findings are expected to show that a digitalized program designed to engage youth in smoking cessation can result in quitting smoking and has a high applicability potential especially among the hard-to-reach population of youth.
Study Type
Interventional
Enrollment (Anticipated)
300
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Non-US/Non-Canadian
-
Nicosia, Non-US/Non-Canadian, Cyprus, 1678
- Recruiting
- University of Cyprus
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
15 years to 30 years (Child, Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Regular smoker (at least 1 cigarette per day)
- Parental consent for those under 18years of age
Exclusion Criteria:
- Currently enrolled in another smoking cessation program
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Waitlist control
Wait-list control group
|
|
Experimental: Flexiquit
Digital ACT-based intervention for smoking cessation
|
Digital avatar-led Acceptance and Commitment Therapy for smoking cessation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Quit rate
Time Frame: Post-intervention (following completion of digital session 5) and follow-up (3 months and 6 months after post-intervention)
|
Change in Smoking quit status at each assessment point
|
Post-intervention (following completion of digital session 5) and follow-up (3 months and 6 months after post-intervention)
|
Change in Number of cigarettes
Time Frame: Post-intervention (following completion of digital session 5) and follow-up (3 months and 6 months after post-intervention)
|
Change in the number of cigarettes smoked per day
|
Post-intervention (following completion of digital session 5) and follow-up (3 months and 6 months after post-intervention)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Nicotine Dependence
Time Frame: Post-intervention (following completion of digital session 5) and follow-up (3 months and 6 months after post-intervention)
|
Change in the Fagerstrom Test of Nicotine Dependence scores
|
Post-intervention (following completion of digital session 5) and follow-up (3 months and 6 months after post-intervention)
|
Change in Readiness to quit
Time Frame: Post-intervention (following completion of digital session 5) and follow-up (3 months and 6 months after post-intervention)
|
Change in the Contemplation Ladder assessing stages of change
|
Post-intervention (following completion of digital session 5) and follow-up (3 months and 6 months after post-intervention)
|
Change in self-efficacy to not smoke in specific situations
Time Frame: Post-intervention (following completion of digital session 5) and follow-up (3 months and 6 months after post-intervention)
|
Change in Smoking Self-Efficacy Questionnaire scores
|
Post-intervention (following completion of digital session 5) and follow-up (3 months and 6 months after post-intervention)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 15, 2017
Primary Completion (Anticipated)
July 30, 2019
Study Completion (Anticipated)
July 30, 2020
Study Registration Dates
First Submitted
August 7, 2018
First Submitted That Met QC Criteria
August 10, 2018
First Posted (Actual)
August 15, 2018
Study Record Updates
Last Update Posted (Actual)
August 21, 2018
Last Update Submitted That Met QC Criteria
August 17, 2018
Last Verified
August 1, 2018
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- ΕΕΒΚ/ΕΠ/2013/05
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Smoking Cessation
-
University of Southern CaliforniaAmerican Cancer Society, Inc.CompletedSmoking | Smoking Cessation | Smoking, Cigarette | Smoking Behaviors | Cessation, SmokingUnited States
-
Nabi BiopharmaceuticalsNational Institute on Drug Abuse (NIDA)CompletedSmoking | Smoking Cessation | Tobacco CessationUnited States
-
Claremont Graduate UniversityNational Cancer Institute (NCI)CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Cessation | Smoking, CigaretteUnited States
-
Heidelberg UniversityPfizerTerminatedSmoking | Smoking Cessation | Tobacco Use CessationGermany
-
Mayo ClinicNational Institute on Drug Abuse (NIDA)CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Cessation | Smoking, Tobacco | Smoking, CigaretteUnited States
-
University of MiamiFlorida Department of HealthRecruitingSmoking Cessation | Tobacco Smoking | Tobacco Use CessationUnited States
-
University of VermontMayo Clinic; Alaska Native Tribal Health ConsortiumTerminatedSmoking | Smoking CessationUnited States
-
University of Wisconsin, MadisonCentiment LLCCompletedSmoking | Smoking CessationUnited States
-
Yale UniversityCompletedSmoking | Smoking CessationUnited States
-
Johns Hopkins UniversityMaryland Department of Health and Mental HygieneCompletedCOach2Quit TRIAL: Assessing a Prototype Personal Carbon Monoxide Monitor for Smoking Cessation (C2Q)Smoking | Smoking CessationUnited States